The average one-year price target for Unicycive Therapeutics (NASDAQCM:UNCY) has been revised to $32.54 / share. This is an increase of 12.32% from the prior estimate of $28.97 dated September 29, 2026. These figures represent aggregate analyst targets and do not constitute a rec